Skip to main content

Amphastar Pharmaceuticals, Inc.

AMPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001297184

In the last 90 days, Amphastar Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 227 institutions reported holding it in 13F filings for Q3 2026, worth $754.6M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 19, 2026
$1.20B
Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $1.56M in total
5
13F holdersQ3 2026, +18 vs. previous quarter
227
13F valueReported value at the end of Q3 2026
$754.6M
Superinvestors holdingAt the end of Q3 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
$719.9M
−1.7% year over year
Net income, FY2025
$98.1M
−38.5% year over year
Free cash flow, FY2025
$121.2M
−29.7% year over year
Revenue, Q3 FY2026
$207.6M
+8.2% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
4.26M
Shares sold short
Change
−72.3K
−1.7% vs. previous
Days to cover
11.34
At average daily volume

Superinvestors holding AMPH, Q3 2026

Go to the superinvestors tab

No superinvestor reported holding AMPH at the end of Q3 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Amphastar Pharmaceuticals, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 18, 2026 (view filing)4:11 PM ETNov 162 daysPeters William JCFO, EVP & TREASURERSSale−11.0K$29.99−$329.9K−6.2%167.1K after10b5-1
Nov 6, 2026 (view filing)4:17 PM ETNov 4-52 daysPeters William JCFO, EVP & TREASURERSSale−28.6K$28.45−$814.7K−14.6%167.1K after2 lots10b5-1
Sep 23, 2026 (view filing)6:02 PM ETSep 212 daysPeters William JCFO, EVP & TREASURERSSale−4.14K$25.00−$103.5K−2.4%168.7K after10b5-1
Sep 17, 2026 (view filing)6:19 PM ETSep 161 dayZhou RongSENIOR EVP, PRODUCTION CENTERSSale−10.0K$23.94−$239.4K−5.6%169.2K after
Sep 3, 2026 (view filing)7:42 PM ETSep 21 dayZhou RongSENIOR EVP, PRODUCTION CENTERSSale−3.19K$23.63−$75.3K−1.8%169.2K after
Aug 12, 2026 (view filing)6:14 PM ETAug 111 dayPrins Richard KDirectorSSale−7.97K$20.30−$161.9K−21.2%29.6K after
Aug 11, 2026 (view filing)4:57 PM ETAug 74 daysPeters William JCFO, EVP & TREASURERSSale−8.18K$22.48−$183.9K−4.5%172.8K after10b5-1
Dec 18, 2025 (view filing)Dec 171 dayZhou RongSENIOR EVP, PRODUCTION CENTERSSale−9.79K$26.20−$256.4K−6.6%138.0K after
Dec 15, 2025 (view filing)Dec 11-124 daysPetersen Floyd F.DirectorSSale−4.16K$25.82−$107.5K−5.5%71.4K after2 lots
Nov 25, 2025 (view filing)Nov 25Same dayPrins Richard KDirectorSSale−4.18K$27.10−$113.3K−10.6%35.2K after

Top 10 13F holders, Q3 2026

See all 227 holders

The largest institutional positions in Amphastar Pharmaceuticals, Inc. at the end of Q3 2026; share changes are against Q2 2026.

Institutions holding AMPH in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.5,118,737$132.1M0.00%−106,197−2.0%Reduced
Dimensional Fund Advisors LP2,382,991$61.5M0.01%+77,884+3.4%Added
State Street Corp1,674,060$43.2M0.00%+31,934+1.9%Added
American Century Companies Inc1,585,068$40.9M0.02%+408,442+34.7%Added
Vanguard Capital Management LLC1,239,347$32.0M0.00%−242,605−16.4%Reduced
Marshall Wace, LLP1,216,253$31.4M0.03%+149,931+14.1%Added
D. E. Shaw & Co., Inc.1,145,129$29.6M0.02%+258,081+29.1%Added
Geode Capital Management, LLC970,452$25.1M0.00%+612+0.1%Added
Fuller & Thaler Asset Management, Inc.922,964$23.8M0.07%−26,274−2.8%Reduced
Vanguard Portfolio Management LLC803,869$20.7M0.00%−5,699−0.7%Reduced

Holders of 5% or more of AMPH

See all 3 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Amphastar Pharmaceuticals, Inc..

Largest holders of AMPH from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Zhang Jack Y.13G/A24.80%12.5M shares–Feb 12, 20215 filingsFeb 7, 2025SEC
BlackRock, Inc.13G/A11.50%5.33M shares–Oct 17, 20251 filingOct 17, 2025SEC
Dimensional Fund Advisors LP13G5.20%2.31M sharesNewJul 14, 20261 filingJul 14, 2026SEC